Clinical Trial Update: Li-Fraumeni Syndrome/TP53 Biobank

View source ↗

Summary

An ongoing Li-Fraumeni syndrome TP53 biobank trial is recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Li-fraumeni Syndrome
• Li-fraumeni-like Syndrome

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Li-Fraumeni Syndrome, Li-Fraumeni-Like Syndrome | Status: RECRUITING